Cargando…

Expression of Toll-Like Receptors 3, 7, and 9 in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is an autoimmune disease of unknown aetiology. The results of experimental studies point to the involvement of innate immunity receptors—toll-like receptors (TLR)—in the pathogenesis of the disease. The aim of the study was to assess the expression of TLR3, 7, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klonowska-Szymczyk, Agnieszka, Wolska, Anna, Robak, Tadeusz, Cebula-Obrzut, Barbara, Smolewski, Piotr, Robak, Ewa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955595/ https://www.ncbi.nlm.nih.gov/pubmed/24692849 http://dx.doi.org/10.1155/2014/381418

Ejemplares similares

Clinical significance of circulating dendritic cells in patients with systemic lupus erythematosus.
por: Robak, E, et al.
Publicado: (2004)

Toll-like receptors and their role in carcinogenesis and anti-tumor treatment
por: Wolska, Anna, et al.
Publicado: (2008)

Pro-Apoptotic Activity of New Honokiol/Triphenylmethane Analogues in B-Cell Lymphoid Malignancies
por: Mędra, Aleksandra, et al.
Publicado: (2016)

Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus.
por: Robak, Ewa, et al.
Publicado: (2003)

Impaired apoptosis of megakaryocytes and bone marrow mononuclear cells in essential thrombocythemia: correlation with JAK2V617F mutational status and cytoreductive therapy
por: Treliński, Jacek, et al.
Publicado: (2012)

Atypical Chronic Lymphocytic Leukemia—The Current Status
por: Robak, Tadeusz, et al.
Publicado: (2023)

Circulating Total and Active Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinases-1 in Patients with Systemic Lupus Erythomatosus
por: Robak, Ewa, et al.
Publicado: (2006)

The Role of Bruton’s Kinase Inhibitors in Chronic Lymphocytic Leukemia: Current Status and Future Directions
por: Robak, Tadeusz, et al.
Publicado: (2022)

Novel Clofarabine-Based Combinations with Polyphenols Epigenetically Reactivate Retinoic Acid Receptor Beta, Inhibit Cell Growth, and Induce Apoptosis of Breast Cancer Cells
por: Lubecka, Katarzyna, et al.
Publicado: (2018)

Exhaled IL-8 in Systemic Lupus Erythematosus with and without Pulmonary Fibrosis
por: Nielepkowicz-Goździńska, Agnieszka, et al.
Publicado: (2014)

Imbalance of Th17 and T-regulatory cells in peripheral blood and synovial fluid in treatment naïve children with juvenile idiopathic arthritis
por: Szymańska-Kałuża, Joanna, et al.
Publicado: (2014)

Lymphocyctes Tgammadelta in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activity.
por: Robak, E, et al.
Publicado: (2001)

The role of endocan and selected pro-inflammatory cytokines in systemic lupus erythematosus
por: Tokarska, Kamila, et al.
Publicado: (2019)

Circulating TCR gammadelta cells in the patients with systemic lupus erythematosus.
por: Robak, E, et al.
Publicado: (1999)

The role of NF-κB and Smac/DIABLO proteins in the treatment response and survival of acute myeloid leukemia patients
por: Pluta, Agnieszka, et al.
Publicado: (2019)

Safety and Tolerability of Antibody-Drug Conjugates in Cancer
por: Wolska-Washer, Anna, et al.
Publicado: (2019)

Zanubrutinib for the treatment of lymphoid malignancies: Current status and future directions
por: Wolska-Washer, Anna, et al.
Publicado: (2023)

Bruton’s Kinase Inhibitors for the Treatment of Immunological Diseases: Current Status and Perspectives
por: Robak, Ewa, et al.
Publicado: (2022)

Cytokine and Chemokine Profile in Patients with Multiple Myeloma Treated with Bortezomib
por: Robak, Paweł, et al.
Publicado: (2020)

Allergic diseases, drug adverse reactions and total immunoglobulin E levels in lupus erythematosus patients.
por: Wozniacka, Anna, et al.
Publicado: (2003)

Variability of the rs333 in Polish patients with lupus erythematosus
por: Mlicka, Dominika, et al.
Publicado: (2021)

Vitamin D Receptor Gene BsmI Polymorphism in Polish Patients with Systemic Lupus Erythematosus
por: Kaleta, Beata, et al.
Publicado: (2013)

Leukemia Cutis—The Current View on Pathogenesis, Diagnosis, and Treatment
por: Robak, Ewa, et al.
Publicado: (2023)

X-linked TLR7 gene polymorphisms are associated with diverse immunological conditions but not with discoid lupus erythematosus in Polish patients
por: Skonieczna, Katarzyna, et al.
Publicado: (2018)

Cytotoxic Activity of Melatonin Alone and in Combination with Doxorubicin and/or Dexamethasone on Diffuse Large B-Cell Lymphoma Cells in In Vitro Conditions
por: Mańka, Sylwia, et al.
Publicado: (2023)

Skin changes in hairy cell leukemia
por: Robak, Ewa, et al.
Publicado: (2020)

The Prognostic Value of Whole-Blood PSMB5, CXCR4, POMP, and RPL5 mRNA Expression in Patients with Multiple Myeloma Treated with Bortezomib
por: Robak, Pawel, et al.
Publicado: (2021)

Psychiatric disorders in patients with systemic lupus erythematosus: association of anxiety disorder with shorter disease duration
por: Hawro, Tomasz, et al.
Publicado: (2010)

The Value of Serum MicroRNA Expression Signature in Predicting Refractoriness to Bortezomib-Based Therapy in Multiple Myeloma Patients
por: Robak, Paweł, et al.
Publicado: (2020)

Dysbiosis in Peripheral Blood Mononuclear Cell Virome Associated With Systemic Lupus Erythematosus
por: Guo, Gangqiang, et al.
Publicado: (2020)

Current Status of Older and New Purine Nucleoside Analogues in the Treatment of Lymphoproliferative Diseases
por: Robak, Tadeusz, et al.
Publicado: (2009)

Bortezomib for the Treatment of Hematologic Malignancies: 15 Years Later
por: Robak, Pawel, et al.
Publicado: (2019)

Measurable residual disease in hairy cell leukemia: Technical considerations and clinical significance
por: Robak, Tadeusz, et al.
Publicado: (2022)

Toll-like receptors 7 and 9 regulate the proliferation and differentiation of B cells in systemic lupus erythematosus
por: Wen, Luyao, et al.
Publicado: (2023)

Contribution of toll-like receptor 9 gene single-nucleotide polymorphism to systemic lupus erythematosus
por: Piotrowski, Piotr, et al.
Publicado: (2012)

The identification of circular RNAs from peripheral blood mononuclear cells in systemic lupus erythematosus
por: Zheng, Fengping, et al.
Publicado: (2021)

RNA-seq analysis of molecular heterogeneity peripheral blood mononuclear cells in systemic lupus erythematosus
por: Xue, Ke, et al.
Publicado: (2019)

Application of New Drugs in Chronic Lymphocytic Leukemia
por: Robak, Tadeusz
Publicado: (2010)

Book review: Safety of Biologics Therapy
por: Robak, Tadeusz
Publicado: (2017)

The Significance of mRNA in the Biology of Multiple Myeloma and Its Clinical Implications
por: Puła, Anna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tnos9k220nj5iad52klta3vkuq